Please use this identifier to cite or link to this item: http://hdl.handle.net/10773/27856
Title: Guanabenz inhibits TLR9 signaling through a pathway that is independent of eIF2α dephosphorylation by the GADD34/PP1c complex
Author: Perego, Jessica
Mendes, Andreia
Bourbon, Clarisse
Camosseto, Voahirana
Combes, Alexis
Hong Liu
Manh, Thien-Phong Vu
Dalet, Alexandre
Chasson, Lionel
Spinelli, Lionel
Bardin, Nathalie
Chiche, Laurent
Santos, Manuel A. S.
Gatti, Evelina
Pierre, Philippe
Issue Date: 23-Jan-2018
Publisher: American Association for the Advancement of Science
Abstract: Endoplasmic reticulum (ER) stress triggers or amplifies inflammatory signals and cytokine production in immune cells. Upon the resolution of ER stress, the inducible phosphatase 1 cofactor GADD34 promotes the dephosphorylation of the initiation factor eIF2α, thereby enabling protein translation to resume. Several aminoguanidine compounds, such as guanabenz, perturb the eIF2α phosphorylation-dephosphorylation cycle and protect different cell or tissue types from protein misfolding and degeneration. We investigated how pharmacological interference with the eIF2α pathway could be beneficial to treat autoinflammatory diseases dependent on proinflammatory cytokines and type I interferons (IFNs), the production of which is regulated by GADD34 in dendritic cells (DCs). In mouse and human DCs and B cells, guanabenz prevented the activation of Toll-like receptor 9 (TLR9) by CpG oligodeoxynucleotides or DNA-immunoglobulin complexes in endosomes. In vivo, guanabenz protected mice from CpG oligonucleotide-dependent cytokine shock and decreased autoimmune symptom severity in a chemically induced model of systemic lupus erythematosus. However, we found that guanabenz exerted its inhibitory effect independently of GADD34 activity on eIF2α and instead decreased the abundance of CH25H, a cholesterol hydroxylase linked to antiviral immunity. Our results therefore suggest that guanabenz and similar compounds could be used to treat type I IFN-dependent pathologies and that CH25H could be a therapeutic target to control these diseases.
Peer review: yes
URI: http://hdl.handle.net/10773/27856
DOI: 10.1126/scisignal.aam8104
ISSN: 1945-0877
Appears in Collections:IBIMED - Artigos

Files in This Item:
File Description SizeFormat 
eaam8104.full.pdf6.04 MBAdobe PDFView/Open


FacebookTwitterLinkedIn
Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.